UltraGene Combo2Screen SARS-CoV-2 Assay Now Registered at the ALMBiH in Bosnia

We are pleased to announce today that the RT-PCR test for COVID-19 detection UltraGene® Combo2Screen SARS-CoV-2 assay is now officially registered at the ALMBiH in Bosnia.

To learn more about UltraGene® Combo2Screen SARS-CoV-2 assay, please visit https://www.ablsa.com/laboratory-applications/ultragene-combo2screen/